123 related articles for article (PubMed ID: 37848025)
1. In vivo photopharmacology with light-activated opioid drugs.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; He XJ; Zhou J; Chang-Weinberg J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
Neuron; 2023 Dec; 111(24):3926-3940.e10. PubMed ID: 37848025
[TBL] [Abstract][Full Text] [Related]
2.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; Jenny He X; Zhou J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778286
[TBL] [Abstract][Full Text] [Related]
3. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
4. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
5. In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior.
Ma X; Johnson DA; He XJ; Layden AE; McClain SP; Yung JC; Rizzo A; Bonaventura J; Banghart MR
Nat Methods; 2023 May; 20(5):682-685. PubMed ID: 36973548
[TBL] [Abstract][Full Text] [Related]
6. μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice.
Wiskerke J; Schetters D; van Es IE; van Mourik Y; den Hollander BR; Schoffelmeer AN; Pattij T
J Neurosci; 2011 Jan; 31(1):262-72. PubMed ID: 21209211
[TBL] [Abstract][Full Text] [Related]
7. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
[TBL] [Abstract][Full Text] [Related]
8. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
Borg PJ; Taylor DA
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
[TBL] [Abstract][Full Text] [Related]
10. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
11. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects.
López-Cano M; Font J; Aso E; Sahlholm K; Cabré G; Giraldo J; De Koninck Y; Hernando J; Llebaria A; Fernández-Dueñas V; Ciruela F
Br J Pharmacol; 2023 Apr; 180(7):958-974. PubMed ID: 34363210
[TBL] [Abstract][Full Text] [Related]
12. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis on reciprocal interactions between the central and peripheral components of the endogenous opioid system.
Sudakov SK; Trigub MM
Bull Exp Biol Med; 2008 Dec; 146(6):663-6. PubMed ID: 19513349
[TBL] [Abstract][Full Text] [Related]
14. Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward.
Beierle JA; Yao EJ; Goldstein SI; Lynch WB; Scotellaro JL; Shah AA; Sena KD; Wong AL; Linnertz CL; Averin O; Moody DE; Reilly CA; Peltz G; Emili A; Ferris MT; Bryant CD
J Pharmacol Exp Ther; 2022 Aug; 382(2):167-180. PubMed ID: 35688478
[TBL] [Abstract][Full Text] [Related]
15. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
16. Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.
Terashvili M; Talluri B; Palangmonthip W; Iczkowski KA; Sanvanson P; Medda BK; Banerjee B; Cunningham CW; Sengupta JN
Neuropharmacology; 2021 Sep; 196():108701. PubMed ID: 34256047
[TBL] [Abstract][Full Text] [Related]
17. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: studies using mu-opioid receptor gene knockout mice.
Jang C; Park Y; Tanaka S; Ma T; Loh HH; Ho IK
Brain Res Mol Brain Res; 2000 May; 78(1-2):204-6. PubMed ID: 10891603
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Profile of Naldemedine, a Peripherally Acting
Kanemasa T; Koike K; Takase K; Arai T; Nakamura A; Morioka Y; Hasegawa M
J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839
[TBL] [Abstract][Full Text] [Related]
20. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
